Humanized anti-DEspR IgG4S228P antibody increases overall survival in a pancreatic cancer stem cell-xenograft peritoneal carcinomatosis ratnu/nu model

Overview of attention for article published in BMC Cancer, April 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (80th percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

So far, Altmetric has seen 9 X posts from 9 X users, with an upper bound of 15,681 followers.

RT @Grinstaff: Our clinician researchers & engineers at @BU_Tweets are focused on improving treatment outcomes & prolonging cancer-free liv…

RT @Grinstaff: Our clinician researchers & engineers at @BU_Tweets are focused on improving treatment outcomes & prolonging cancer-free liv…

RT @Grinstaff: Our clinician researchers & engineers at @BU_Tweets are focused on improving treatment outcomes & prolonging cancer-free liv…

Our clinician researchers & engineers at @BU_Tweets are focused on improving treatment outcomes & prolonging cancer-free lives of patients. #StandUpToCancer #sciencesaveslives #CancerResearch @SU2C @BUCollegeofENG @The_BMC @BUMedicine #PancreaticCa

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 5 additional X posts.